MC
LLY icon

Maverick Capital’s Eli Lilly LLY Stock Holding History

Maverick Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-58,901
Closed -$45.9M – 279
2025
Q2 		$45.9M Buy
+58,901
New +$45.8M 0.69% 39
2024
Q1 		– Sell
-2,002
Closed -$1.17M – 493
2023
Q4 		$1.17M Buy
2,002
+363
+22% +$212K 0.02% 112
2023
Q3 		$880K Buy
+1,639
New +$845K 0.02% 133
2021
Q4 		– Sell
-3,331
Closed -$770K – 499
2021
Q3 		$770K Buy
3,331
+1,833
+122% +$452K 0.01% 374
2021
Q2 		$344K Buy
+1,498
New +$301K ﹤0.01% 423
2020
Q4 		– Sell
-5,349
Closed -$792K – 734
2020
Q3 		$792K Buy
+5,349
New +$828K 0.01% 334

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Maverick Capital's LLY Position: Q3 2025 in Review

Maverick Capital sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 58,901 shares — an estimated $45.9M sold.

Maverick Capital first reported a position in LLY in Q3 2020 and held it in 6 quarters. The position peaked at $45.9M in Q2 2025. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Maverick Capital reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • Maverick Capital sold 58,901 Eli Lilly shares in Q3 2025, an estimated $45.9M.
  • Maverick Capital first reported a position in Eli Lilly in Q3 2020 and held it in 6 quarters.
  • Maverick Capital's Eli Lilly position peaked at $45.9M in Q2 2025.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Maverick Capital's 13F filing for Q3 2025, filed 14 Nov 2025.